arrow_back Back to App

Longer Drug Expiration Dates: Reducing Shortages

This act aims to reduce drug shortages by allowing longer expiration dates for certain medications. This means drugs could remain available for use longer, potentially improving patient access and reducing the risk of pharmacies running out.
Key points
Health authorities will develop guidelines for manufacturers to propose longer drug expiration dates when scientifically supported and safe.
The law seeks to prevent drug shortages, benefiting patients who rely on consistent access to their medications.
There will be ongoing reporting on how many drugs have extended expiration dates and their impact on shortage prevention.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_7669
Sponsor: Rep. Matsui, Doris O. [D-CA-6]
Process start date: 2022-05-06
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Drug Shortages Shelf Life Extension Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_7669.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-05-06.

What are the main provisions?

Key points include:

  • Health authorities will develop guidelines for manufacturers to propose longer drug expiration dates when scientifically supported and safe.
  • The law seeks to prevent drug shortages, benefiting patients who rely on consistent access to their medications.
  • There will be ongoing reporting on how many drugs have extended expiration dates and their impact on shortage prevention.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Matsui, Doris O. [D-CA-6].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health